Dark Forest Capital Management’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-21,760
Closed -$1.81M 918
2026
Q1
$1.81M Sell
21,760
-17,447
-44% -$1.38M 0.16% 178
2025
Q4
$3.05M Buy
39,207
+8,155
+26% +$551K 0.14% 227
2025
Q3
$1.76M Buy
31,052
+5,102
+20% +$230K 0.07% 511
2025
Q2
$1.13M Sell
25,950
-28,204
-52% -$971K 0.05% 697
2025
Q1
$1.48M Buy
54,154
+43,905
+428% +$1.6M 0.07% 497
2024
Q4
$412K Buy
10,249
+5,839
+132% +$264K 0.06% 525
2024
Q3
$209K Buy
+4,410
New +$195K 0.03% 852
2023
Q4
Sell
-36,698
Closed -$510K 809
2023
Q3
$510K Buy
36,698
+17,280
+89% +$347K 0.04% 711
2023
Q2
$446K Buy
19,418
+11,376
+141% +$326K 0.04% 674
2023
Q1
$238K Buy
+8,042
New +$259K 0.06% 315
2022
Q4
Sell
-267
Closed -$6K 1330
2022
Q3
$6K Sell
267
-231
-46% -$6.09K ﹤0.01% 849
2022
Q2
$10K Buy
498
+425
+582% +$9.93K ﹤0.01% 528
2022
Q1
$3K Buy
73
+4
+6% +$169 ﹤0.01% 1147
2021
Q4
$4K Sell
69
-779
-92% -$45.4K ﹤0.01% 1227
2021
Q3
$50K Buy
848
+823
+3,292% +$47.7K 0.02% 564
2021
Q2
$1K Buy
+25
New +$1.08K ﹤0.01% 784

Other funds holding KYMR

Dark Forest Capital Management's KYMR Position: Q2 2026 in Review

Dark Forest Capital Management sold out of Kymera Therapeutics (KYMR) in Q2 2026, closing a stake of 21,760 shares — an estimated $1.81M sold.

Dark Forest Capital Management first reported a position in KYMR in Q2 2021 and held it in 16 quarters. The position peaked at $3.05M in Q4 2025. 277 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

  • Dark Forest Capital Management reported no remaining Kymera Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Dark Forest Capital Management sold 21,760 Kymera Therapeutics shares in Q2 2026, an estimated $1.81M.
  • Dark Forest Capital Management first reported a position in Kymera Therapeutics in Q2 2021 and held it in 16 quarters.
  • Dark Forest Capital Management's Kymera Therapeutics position peaked at $3.05M in Q4 2025.
  • 277 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.